Colorectal
Signal score, how each part rates
ActionabilityPrevalenceStakesEvidence strengthNovelty
See the full rubric →Contemporary hormonal contraception and colorectal cancer in premenopausal women: nationwide cohort study.
Clinical takeawayNo need to modify contraceptive counseling or colorectal cancer screening practices based on hormonal contraceptive use in premenopausal women aged 15-49, as modern products neither increase nor decrease risk.
What it foundCurrent or recent use of contemporary hormonal contraception did not substantially affect colorectal cancer risk, with incidence rate ratios of 0.94 (95% CI 0.83 to 1.06) for all users and 0.86 (0.62 to 1.18) for those with more than 10 years of use.
ContextThis confirms prior evidence that hormonal contraception does not significantly influence colorectal cancer risk, addressing concerns about rising incidence in young women.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Lange IH … Mørch LS · BMJ · IF 42.7 · PubMed ↗